Dynamic changes in cellular and microenvironmental composition can be controlled to elicit in vitro human hematopoietic stem cell expansion

This publication has 61 references indexed in Scilit:

• Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment
  Blood, 2004
• Clinical application of hematopoietic progenitor cell expansion: current status and future prospects
  Bone Marrow Transplantation, 2003
• In vitro expansion of cord blood does not prevent engraftment of severe combined immunodeficient repopulating cells
  British Journal of Haematology, 2002
• Umbilical cord blood progeny cells that retaina CD34+ phenotype after ex vivo expansion have less engraftment potential than unexpanded CD34+ cells
  Transfusion, 2001
• Specific dose-response effects of TGF-β1 on developmentally distinct hematopoietic stem/progenitor cells from human umbilical cord blood
  The Hematology Journal, 2000
• Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor
  Journal of Clinical Investigation, 2000
• Release from Quiescence of Primitive Human Hematopoietic Stem/Progenitor Cells by Blocking Their Cell‐Surface TGF‐β Type II Receptor in a Short‐Term In Vitro Assay
  The International Journal of Cell Cloning, 2000
• Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells
  The Lancet, 1999
• Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines.
  Journal of Clinical Investigation, 1996
• Culture perfusion schedules influence the metabolic activity and granulocyte‐macrophage colony‐stimulating factor production rates of human bone marrow stromal cells
  Journal of Cellular Physiology, 1991